Understanding differences in bioreactor lifecycle, design space, and product platforms is important for selecting a bioreactor type.
The experience gained and knowledge compiled from legacy biomanufacturing operations establish a reference. This reference can benefit a thorough assessment of new methods and technologies, and it can aid in the transition or adoption of new approaches. With respect to stainless-steel and single-use bioreactors, lifecycle, design space, and product platform concepts are discussed in this article.
Read this article in BioPharm International's Single-Use Systems 2018 eBook.
BioPharm International
eBook: Single-Use Systems 2018
Vol. 31
June 2018
Pages: 41–46
When referring to this article, please cite it as K. Clapp, "Comparing the Supply Lifecycle of Bioreactors," Single-Use Systems eBook (June 2018).
Thermo Fisher Opens Advanced Therapies Collaboration Center in California
April 18th 2025The 6000-square-foot facility will provide cell therapy developers the support they need to transition to CGMP manufacturing, and an expanded footprint of the new center is expected to open in Philadelphia later in 2025.